Syndax Pharmaceuticals SNDX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's short-term investments?
- Syndax Pharmaceuticals (SNDX) reported short-term investments of $221.17M in Q1 2026.
- How has Syndax Pharmaceuticals's short-term investments changed year-over-year?
- Syndax Pharmaceuticals's short-term investments decreased by 38.3% year-over-year, from $358.2M to $221.17M.
- What is the long-term trend for Syndax Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's short-term investments has grown at a 7.8% compound annual growth rate (CAGR), from $177.82M to $259.14M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.